跳至主要内容
临床试验/NCT07686250
NCT07686250招募中2 期

Clinical Evaluation and Outcomes of Multi-signal SAVI Scout (Scout MD) Localized Breast Conserving Surgery

H. Lee Moffitt Cancer Center and Research Institute1 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2026年7月29日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
招募中
入组人数
37
试验地点
1
主要终点
Successful Operation Rate (SOR)

研究概览

简要总结

The purpose of the study is to evaluate how precise the SAVI Scout MD is and how easy it is for surgeons to use during surgery. The SAVI Scout MD system uses tiny radar reflectors instead of wires, can be placed days or weeks before surgery, helps surgeons find the cancer more precisely and may lower the chance of needing a second surgery.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Adult females who are 18 years of age or older at time of signing informed consent will be eligible.
  • Must have ability to comprehend and the willingness to sign written informed consent for study participation.
  • Patients must have at least one sonographically, mammographically, or MRI identifiable in-breast malignancy and consent to undergo a surgical resection requiring bracketed localization (more than one localizing marker) at Moffitt Cancer Center. Mammographically or sonographically visible biopsy clips may be used as a localizing target.

排除标准

  • Patients undergoing mastectomy for resection of the targeted lesion.
  • Planned excision of multiple separate sites in the ipsilateral breast.
  • Inability to undergo surgery at Moffitt Cancer Center.

研究组 & 干预措施

SAVI Scout MD Localization

Experimental

Participants undergo image-guided placement of multiple Scout MD reflectors followed by breast-conserving surgery using the device for intraoperative localization.

干预措施: SAVI Scout MD system (Device)

结局指标

主要结局

Successful Operation Rate (SOR)

时间窗: Up to 6 weeks.

Proportion of patients achieving complete tumor resection with negative surgical margins ("no tumor on ink" or ≥2 mm for DCIS).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验